Foseco India Q3 FY25: profit dips on acquisition cost, 9M revenue up 17.5%
FOSECOIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 3.1 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Foseco India Q3 FY25 revenue rose 7.1% YoY to Rs 15,071.57 lakhs, but net profit dipped to Rs 1,648.51 lakhs from Rs 1,855.56 lakhs due to a Rs 479.85 lakh exceptional expense linked to the proposed Morganite Crucible India acquisition. For 9M FY25, revenue grew 17.5% to Rs 45,648 lakhs and net profit rose 11.6% to Rs 5,969 lakhs. The company plans to acquire 75% in MCIL for Rs 65,394 lakhs via share swap; BSE and NSE in-principle approval received. Auditors issued an unmodified review report.
Acquisition-related exceptional costs weighed on Q3 profit; share-swap deal for MCIL could transform scale once completed. 9M topline growth healthy.